E T Creagan, J Rubin, C G Moertel, A J Schutt, M J O'connell, R G Hahn, R J Reitemeir, S Frytak. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Adenocarcinoma/drug therapyAdenocarcinoma/immunologyAntibiotics, Antineoplastic/administration & dosageAntibiotics, Antineoplastic/adverse effectsAntibiotics, Antineoplastic/therapeutic useColonic Neoplasms/drug therapyColonic Neoplasms/immunologyDigestive System/drug effectsHumansLeukopenia/chemically inducedLymphocytes/immunologyPrognosisRectal Neoplasms/drug therapyRectal Neoplasms/immunologyRibonucleosides/administration & dosageRibonucleosides/adverse effectsRibonucleosides/therapeutic use
Substances： See more » Antibiotics, AntineoplasticRibonucleosidespyrazofurin
Year: 1977 PMID： 872147
Source DB: PubMed Journal: Cancer Treat Rep ISSN： 0361-5960